Can ibogaine help addiction, PTSD or traumatic brain injury, and what makes its cardiac risks important?

Ibogaine has produced interesting signals in human research, but strong claims run ahead of the study designs. A prospective observational study followed 30 male special-operations veterans with predominantly mild traumatic brain injury who received a magnesium-ibogaine protocol alongside other supportive treatments. Disability, PTSD, depression and anxiety measures improved, but there was no randomized control group. That prevents the study from separating ibogaine’s effect from expectation, support and other changes. Observational opioid-withdrawal work also warrants investigation, rather than establishing a dependable cure for addiction or lasting abstinence.[1][2]

The cardiac concern is concrete: ibogaine can prolong the QT interval, disturbing the timing of the heart’s electrical recovery and creating a risk of dangerous ventricular arrhythmias. Human safety studies have documented clinically important QT prolongation, and cardiac arrests have been reported. A small magnesium-supported study without serious events cannot establish that magnesium eliminates this risk. Careful medical screening and monitoring are essential features of research, not guarantees of safety. Symptom improvement or brain-imaging changes also do not, by themselves, prove repair of traumatic brain injury.[1][2][3]